Explore related pages
Related company profiles:
News
ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair - Yahoo Finance
ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair Yahoo Finance
AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas - PR Newswire
AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas PR Newswire
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing - Bain Capital
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing Bain Capital
ADARx Inks $335M Agreement with AbbVie - San Diego Business Journal
ADARx Inks $335M Agreement with AbbVie San Diego Business Journal
AbbVie pays ADARx $335M cash for next-gen siRNA options - Fierce Biotech
AbbVie pays ADARx $335M cash for next-gen siRNA options Fierce Biotech
AbbVie bets $335M upfront for ADARx's gene-silencing tech - FirstWord Pharma
AbbVie bets $335M upfront for ADARx's gene-silencing tech FirstWord Pharma
AbbVie Dives Further Into siRNA With $335M Upfront in ADARx Deal - BioSpace
AbbVie Dives Further Into siRNA With $335M Upfront in ADARx Deal BioSpace
AbbVie & ADARx Partner on Next-Gen siRNA Therapeutics - Contract Pharma
AbbVie & ADARx Partner on Next-Gen siRNA Therapeutics Contract Pharma
Yes siRNA: Adarx/Abbvie tie-up worth “several billion” dollars - BioWorld MedTech
Yes siRNA: Adarx/Abbvie tie-up worth “several billion” dollars BioWorld MedTech
AbbVie and ADARx enter multi-billion dollar partnership to develop siRNA therapies - PMLiVE
AbbVie and ADARx enter multi-billion dollar partnership to develop siRNA therapies PMLiVE
ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic - Business Wire
ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic Business Wire
ADARx doses first subject in Phase III trial of ADX-324 for HAE - Clinical Trials Arena
ADARx doses first subject in Phase III trial of ADX-324 for HAE Clinical Trials Arena
AbbVie stakes $335M on a startup’s RNAi drugs - BioPharma Dive
AbbVie stakes $335M on a startup’s RNAi drugs BioPharma Dive
AbbVie and ADARx Join Forces to Advance Next-Generation siRNA Therapies - Dermatology Times
AbbVie and ADARx Join Forces to Advance Next-Generation siRNA Therapies Dermatology Times
AbbVie expands siRNA push with $335m ADARx deal - Pharmaceutical Technology
AbbVie expands siRNA push with $335m ADARx deal Pharmaceutical Technology
RNA startup ADARx raises $200M from Bain, TCGX to bring RNAi ‘to the next level’ - Endpoints News
RNA startup ADARx raises $200M from Bain, TCGX to bring RNAi ‘to the next level’ Endpoints News
AbbVie, ADARx Pharmaceuticals Partner to Develop Next-Gen siRNA Therapeutics - Yahoo Finance
AbbVie, ADARx Pharmaceuticals Partner to Develop Next-Gen siRNA Therapeutics Yahoo Finance
ADARx Pharmaceuticals Announces Dosing of First Cohort in Phase 1 Clinical Study of ADX-324 - Business Wire
ADARx Pharmaceuticals Announces Dosing of First Cohort in Phase 1 Clinical Study of ADX-324 Business Wire
AbbVie doubles down on siRNA with $335M upfront bet on ADARx - Endpoints News
AbbVie doubles down on siRNA with $335M upfront bet on ADARx Endpoints News
ADARx secures $200m to advance clinical programmes - Pharmaceutical Technology
ADARx secures $200m to advance clinical programmes Pharmaceutical Technology
RNA biotech ADARx hauls in $200M, almost doubling 2 previous raises combined - Fierce Biotech
RNA biotech ADARx hauls in $200M, almost doubling 2 previous raises combined Fierce Biotech
AbbVie and ADARx Pharmaceuticals Announce Collaboration - citybiz
AbbVie and ADARx Pharmaceuticals Announce Collaboration citybiz
Fresh off massive fundraising, ADARx preps 3rd clinical program and mulls IPO - Fierce Biotech
Fresh off massive fundraising, ADARx preps 3rd clinical program and mulls IPO Fierce Biotech
ADARx Pharmaceuticals doses first cohort in Phase I HAE therapy trial - Clinical Trials Arena
ADARx Pharmaceuticals doses first cohort in Phase I HAE therapy trial Clinical Trials Arena
Billions to play for in AbbVie and ADARx siRNA tie-up - The Pharma Letter
Billions to play for in AbbVie and ADARx siRNA tie-up The Pharma Letter
AbbVie paying $355M, potentially billions more, in deal for new RNA tech - Crain's Chicago Business
AbbVie paying $355M, potentially billions more, in deal for new RNA tech Crain's Chicago Business
AbbVie and ADARx to develop siRNA therapeutics for multiple disease areas - Pharmaceutical Business review -
AbbVie and ADARx to develop siRNA therapeutics for multiple disease areas Pharmaceutical Business review -
ADARx Pharmaceuticals Appoints Christopher Prentiss As CFO - citybiz
ADARx Pharmaceuticals Appoints Christopher Prentiss As CFO citybiz
ADARx Nets $200M for Lead siRNA Drug Candidates - Inside Precision Medicine
ADARx Nets $200M for Lead siRNA Drug Candidates Inside Precision Medicine
San Diego biotech lands $46M for treatment targeting life-threatening swelling attacks - San Diego Union-Tribune
San Diego biotech lands $46M for treatment targeting life-threatening swelling attacks San Diego Union-Tribune
Adarx to use $200M in financing to advance its clinical programs - Angioedema News
Adarx to use $200M in financing to advance its clinical programs Angioedema News
AbbVie (ABBV) Enters Agreement with ADARx for RNA Therapies - GuruFocus
AbbVie (ABBV) Enters Agreement with ADARx for RNA Therapies GuruFocus
AbbVie (ABBV) Collaborates with ADARx to Advance siRNA Therapeutics | ABBV Stock News - GuruFocus
AbbVie (ABBV) Collaborates with ADARx to Advance siRNA Therapeutics | ABBV Stock News GuruFocus
Adarx's HAE Therapy ADX-324 Enters Phase 1 Clinical Trial Testing... - Angioedema News
Adarx's HAE Therapy ADX-324 Enters Phase 1 Clinical Trial Testing... Angioedema News
OrbiMed, Lilly Asia Ventures chip into ADARx's $75M round to take RNA tech into the clinic - Fierce Biotech
OrbiMed, Lilly Asia Ventures chip into ADARx's $75M round to take RNA tech into the clinic Fierce Biotech
ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (ASN) Kidney Week 2025 - The Manila Times
ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (ASN) Kidney Week 2025 The Manila Times
Top Adarx Pharmaceuticals Inc. Employees
-
Lisa Ann Melia
Vice President, Clinical Operations
Carlsbad, California, United States, United States5meipharma.com, yahoo.com, regulusrx.com, acadia-pharm.com, shorelinebio.com -
Richard Wong
Bioanalytical And Pharmacokinetics…
San Diego, California, United States, United States6chem.uga.edu, bms.com, gmail.com, neurocrine.com, adarx.com, berkeley.edu3 +162659XXXXX
-
-
Courtnay Buonomo
n/a
Raleigh, North Carolina, United States, United States3yahoo.com, precisionformedicine.com, herontx.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.